- The Jacobs Institute is a one-of-a-kind nonprofit vascular
medical technology innovation center located in Buffalo, NY, that operates at the forefront of
developing the next generation of medical technology for the
treatment of vascular disease.
- Adnan H. Siddiqui, MD, Ph.D.,
CEO/CMO of the Jacobs Institute and Director of Neurosurgical
Stroke Service for Kaleida Health, will moderate each
webinar.
- The first series is scheduled for Tuesday, October 25th at 5 pm EST.
STOCKHOLM, Oct. 11, 2022 /PRNewswire/ -- IRRAS, a
commercial-stage medical technology company with a comprehensive
portfolio of innovative products for neurocritical care, today
announced the launch of a new educational webinar series,
'Exploring the Impact of IRRAflow's Active Fluid Exchange:
Our Early Experience Utilizing IRRAflow for Intracranial
Hemorrhage', with the Jacobs Institute.
During each live webinar, Dr. Adnan
Siddiqui, Chief Executive Officer and Chief Medical Officer
of the Jacobs Institute, will moderate a panel of neurosurgeon
experts in a 60-minute interactive discussion around new treatments
for intracranial hemorrhage. Physician panelists and topics will
vary with each webinar, but the overall subject will focus on the
benefits of utilizing IRRAflow's active fluid exchange to
quickly and efficiently clear blood from the intraventricular
space.
During each episode of the webinar series, Dr. Siddiqui and an
esteemed group of expert panelists will discuss the historical
shortcomings of traditional treatment for patients with
intracranial bleeding and how new technological advances, such as
IRRAS' IRRAflow system, expand the options available to
treat this challenging patient population. In addition, each
physician panelist will discuss their experience incorporating
IRRAflow into their clinical practice and share their
recently published IRRAflow case reviews and ongoing
clinical studies.
"We are excited to partner with the Jacobs Institute, Dr.
Siddiqui, and the University of Buffalo Department of Neurosurgery
to bring together leading experts to discuss the evolution in
treatment for intracranial bleeding," said Will Martin, President and CEO of IRRAS. "Dr.
Siddiqui and his peers in Buffalo
are world-renowned for their contribution to advancing innovation
in the treatment of stroke, and we feel that this webinar series
will create an ideal learning environment where experts share
advice with their peers regarding cutting-edge technology, and
lessons learned during clinical practice."
The IRRAflow Webinar Series
Title: Exploring the Impact of IRRAflow's Active
Fluid Exchange: Our Early Experience Utilizing IRRAflow for
Intracranial Hemorrhage
Date: Tuesday, October 25th
Time: 5 pm EST
Moderator: Adnan H. Siddiqui, MD, Ph.D., CEO/CMO of
the Jacobs Institute, Professor and Vice Chairman of the University
of Buffalo Department of Neurosurgery (UBNS), and Director of
Neurosurgical Stroke Service for Kaleida Health
Panelists:
- Elad Levy, MD, Professor and
Chairman of the University of Buffalo Department of Neurosurgery
(UBNS), President-Elect of the Congress of Neurological Surgeons,
and Co-Director, Gates Stroke Center at Kaleida Health
- Jason Davies, MD, Ph.D.,
Director of Cerebrovascular Microsurgery, Director of Endoscopy,
Kaleida Health
- Ryan Hess, MD, Department of
Neurosurgery, Jacobs School of Medicine & Biomedical
Science
- Will Martin, President and CEO
of IRRAS
Register Here:
https://jacobsinstitute-org.zoom.us/webinar/register/WN_HieJpGtATlO2Z7zfvhYTiQ
About The Jacobs Institute
The Jacobs Institute is a non-profit organization whose mission
is to accelerate the development of next-generation technologies in
vascular medicine through collisions of physicians, engineers,
entrepreneurs, and industry. The JI's vision is to improve the
treatment of vascular disease in Western
New York and the world, while fostering local economic
development. The JI fosters medical collaboration and innovation
through partnerships with the University at
Buffalo (UB), Kaleida Health, and industry, to be a fitting
tribute to the work and memory of Lawrence
D. Jacobs, M.D.
To learn more about the Jacobs Institute, please visit our
website at: https://jacobsinstitute.org.
About IRRAS
IRRAS is a global medical care company focused on delivering
innovative medical solutions to improve the lives of critically ill
patients. IRRAS designs, develops, and commercializes neurocritical
care products that transform patient outcomes and decrease the
overall cost of care by addressing complications associated with
current treatment methodologies. IRRAS markets and sells its
comprehensive, innovative IRRAflow and Hummingbird ICP
Monitoring product lines to hospitals worldwide through its direct
sales organization in the United
States and select European countries as well as an
international network of distribution partners.
IRRAS maintains its headquarters in Stockholm, Sweden, with corporate offices in
Munich, Germany, and San Diego, California, USA. For more
information, please visit www.irras.com.
IRRAS is listed on Nasdaq Stockholm (ticker: IRRAS).
For more information, please contact:
Sten Gustafsson
Director, Investor Relations
sten.gustafsson@irras.com
+46 102 11 5172
The information was released for public disclosure, through
the agency of the contact person above, on October 11, 2022, at 8:30 (CET).
This information was brought to you by Cision
http://news.cision.com
https://news.cision.com/irras/r/irras-announces-new-educational-webinar-series-in-collaboration-with-the-jacobs-institute-and-the-un,c3645915
View original
content:https://www.prnewswire.co.uk/news-releases/irras-announces-new-educational-webinar-series-in-collaboration-with-the-jacobs-institute-and-the-university-of-buffalo-department-of-neurosurgery-301645536.html